Immunoprecise Stock Market Sentiment

IPA
 Stock
  

USD 3.84  0.04  1.05%   

Immunoprecise investor sentiment overview provides quick insight into current market opportunities from investing in Immunoprecise Antibodies. The current market sentiment together Immunoprecise Antibodies' historical and current headlines can help investors to time the market. Many technical investors use Immunoprecise Antibodies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation and Immunoprecise Antibodies Performance.
  
Refresh
Immunoprecise Antibodies stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immunoprecise daily returns and investor perception about the current pice of Immunoprecise Antibodies as well as its diversification or hedging effects on your existing portfolios.

Immunoprecise Latest Sentiment Indicators

200 Day MA
5.43
Short Percent
0.0258
Short Ratio
14.43
Shares Short Prior Month
240.8 K
50 Day MA
4.87
52 Week Low
3.51
Shares Short
231.7 K
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 3.65 percent to Close at 6.33 on November 1 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 1.79 percent in Light Trading on October 29 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies gains 0.64 percent to Close at 6.28 on October 27 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies gains 4.60 percent to Close at 6.60 on October 15 - Equities.com
Equities News
over six months ago at www.investorsobserver.com         
ImmunoPrecise Antibodies Enters into At-The-Market Distribution Agreement of Up to 50 Million - Inve...
Investors Business Daily at Macroaxis
over six months ago at www.marketscreener.com         
ImmunoPrecise Antibodies Announces At-The-Market Facility of up to US50 Million - Form 6-K - Markets...
news
over six months ago at www.marketscreener.com         
ImmunoPrecise Antibodies Investor Presentation October 2021 - Marketscreener.com
news
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 1.46 percent for October 8 - Equities.com
Equities News
over six months ago at m.marketscreener.com         
ImmunoPrecise Antibodies Talem Therapeutics Announces Multi-Target Antibody Discovery Research Colla...
news
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 2.34 percent to Close at 5.85 on October 5 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 0.99 percent for October 4 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies gains 0.49 percent in Light Trading on September 30 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 2.21 percent in Light Trading on September 29 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 3.38 percent in Light Trading on September 24 - Equities.com
Equities News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 0.68 percent on Moderate Volume September 21 - Equities.com
Equities News
There is far too much social signal, news, headlines, and media speculation about Immunoprecise Antibodies that is available to investors today. That information is available publicly through Immunoprecise media outlets and privately through word of mouth or via Immunoprecise internal channels. However, regardless of the origin, that massive amount of Immunoprecise data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunoprecise Antibodies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunoprecise Antibodies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunoprecise Antibodies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunoprecise Antibodies alpha.

Immunoprecise Antibodies Performance against DOW

 Price Growth (%)  
      Timeline 
1
Other04/12/2022
2
IPA Completes Acquisition of Belgian Technology Companies Bi...04/13/2022
3
Other04/14/2022
4
Other04/20/2022
5
ImmunoPrecise Antibodies Form 51-102F3 MATERIAL CHANGE REPOR...04/25/2022
6
IPAs Subsidiary BioStrand Secures Second VLAIO Research Gran...05/09/2022
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation and Immunoprecise Antibodies Performance. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
90.4 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.